Sasaki, Maria das Graças <br/><br/>
Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.  [electronic resource] 

 -  Vaccine  Nov 2003 
 - 4545-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(03)00500-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Adolescent<br/>Adult<br/>Cross-Over Studies<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>HIV Infections--complications<br/>Hepatitis Antibodies--analysis<br/>Hepatitis B Vaccines--adverse effects<br/>Hepatitis B virus--immunology<br/>Humans<br/>Male<br/>Vaccines, Synthetic--immunology